CEOs of multinational pharmaceuticals’ Korean branches suffer

CEO of multinational pharmaceutical companies’ Korean branches, especially Korean CEOs, are going through sufferings. Only within this month, 3 Korean CEOs have either already left or is about to do so.

Although relevant pharmaceutical companies explained the resignations are based on ‘personal reasons,’ the pharmaceutical industry presumed they practically are a part of ‘harsh wind’ in perso...